Unlocking the power of sugar: carbohydrate ligands as key players in nanotherapeutic-assisted targeted cancer therapy
R Swami, S Vij, S Sharma - Nanomedicine, 2024 - Taylor & Francis
Cancer cells need as much as 40-times more sugar than their normal cell counterparts. This
sugar demand is attained by the excessive expression of inimitable transporters on the …
sugar demand is attained by the excessive expression of inimitable transporters on the …
[PDF][PDF] Unlocking the power of sugar: carbohydrate ligands as key players in nanotherapeutic-assisted targeted cancer therapy
R Swami, S Vij, S Sharma - researchgate.net
• Cancer's devastating impact, a leading global cause of death, necessitates effective
treatments.• Chemotherapy, while effective, faces challenges of nonspecificity, causing …
treatments.• Chemotherapy, while effective, faces challenges of nonspecificity, causing …
Unlocking the power of sugar: carbohydrate ligands as key players in nanotherapeutic-assisted targeted cancer therapy.
R Swami, S Vij, S Sharma - Nanomedicine (London, England), 2024 - europepmc.org
Cancer cells need as much as 40-times more sugar than their normal cell counterparts. This
sugar demand is attained by the excessive expression of inimitable transporters on the …
sugar demand is attained by the excessive expression of inimitable transporters on the …
Unlocking the power of sugar: carbohydrate ligands as key players in nanotherapeutic-assisted targeted cancer therapy
R Swami, S Vij, S Sharma - Nanomedicine (London, England) - pubmed.ncbi.nlm.nih.gov
Cancer cells need as much as 40-times more sugar than their normal cell counterparts. This
sugar demand is attained by the excessive expression of inimitable transporters on the …
sugar demand is attained by the excessive expression of inimitable transporters on the …